Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45

Benzinga Newsdesk www.benzinga.com Positive 68.9%

Neg 0% Neu 0% Pos 68.9%

Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $38 to $45.